Quoin Pharmaceuticals Relocates Executive Offices

Ticker: QNRX · Form: 8-K · Filed: Apr 30, 2025 · CIK: 1671502

Quoin Pharmaceuticals, Ltd. 8-K Filing Summary
FieldDetail
CompanyQuoin Pharmaceuticals, Ltd. (QNRX)
Form Type8-K
Filed DateApr 30, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, administrative-update

TL;DR

Quoin Pharma moved its HQ to Ashburn, VA. New phone: (703) 980-4182.

AI Summary

Quoin Pharmaceuticals, Ltd. filed an 8-K on April 30, 2025, reporting other events as of April 29, 2025. The filing indicates a change in the company's principal executive offices to Ashburn, VA, with a new address at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349. The company's telephone number has also been updated to (703) 980-4182.

Why It Matters

This filing signals a change in Quoin Pharmaceuticals' operational base, potentially impacting its administrative functions and accessibility for stakeholders.

Risk Assessment

Risk Level: low — The filing reports administrative changes, not material financial or operational events, posing minimal immediate risk.

Key Players & Entities

  • Quoin Pharmaceuticals, Ltd. (company) — Filer of the 8-K
  • April 29, 2025 (date) — Earliest event date reported
  • April 30, 2025 (date) — Date of report
  • 42127 Pleasant Forest Court Ashburn , VA 20148-7349 (location) — New Principal Executive Offices address
  • ( 703 ) 980-4182 (phone_number) — Registrant's telephone number
  • Cellect Biotechnology Ltd. (company) — Former company name
  • Cellect Biomed Ltd. (company) — Former company name

FAQ

What is the new principal executive office address for Quoin Pharmaceuticals, Ltd.?

The new principal executive office address is 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.

What is the new telephone number for Quoin Pharmaceuticals, Ltd.?

The new telephone number for Quoin Pharmaceuticals, Ltd. is (703) 980-4182.

What is the earliest event date reported in this 8-K filing?

The earliest event date reported is April 29, 2025.

When was this 8-K report filed?

This 8-K report was filed on April 30, 2025.

What were Quoin Pharmaceuticals, Ltd.'s former names?

Quoin Pharmaceuticals, Ltd.'s former names were Cellect Biotechnology Ltd. and Cellect Biomed Ltd.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 30, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.